使FDA

Xiang Li1,2, Yi-Qing Sun3, Miao-Miao Liu1

  • 1Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Scientific reports
|April 18, 2025
PubMed
概括

使用FDA数据研究了与药物相关的结膜炎,这是对眼睛健康的威胁. 特拉洛基努马布,布里莫尼丁,杜皮卢马布和拉塔诺普罗斯特呈现出高风险,眼药的效果比其他药物更快.